Browsing by Author Paridaens, Robert

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2010Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancerCoates, Alan; Cole, Bernard; Crivellari, Diana; Gelber, Richard; Gelber, Shari; Goldhirsch, A; Holmberg, Stig B.; Paridaens, Robert; Price, Karen N.; Thurlimann, B.; School of Public Health: Public HealthAdjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer, Breast Cancer Research and Treatment, vol.123, 1,pp 303-310
2007Cardiovascular Adverse Events During Adjuvant Endocrine Therapy for Early Breast Cancer Using Letrozole or Tamoxifen: Safety Analysis of BIG 1-98 TrialCoates, Alan; Castiglione-Gertsch, Monica; et, al; Forbes, John F.; Keshaviah, Aparna; Mauriac, Louis; Mouridsen, Henning; Paridaens, Robert; Rabaglio, Manuela; Sun, Zhuoxin; Thurlimann, Beat; School of Public Health: Public HealthCardiovascular Adverse Events During Adjuvant Endocrine Therapy for Early Breast Cancer Using Letrozole or Tamoxifen: Safety Analysis of BIG 1-98 Trial, JOURNAL OF CLINICAL ONCOLOGY 2005, vol.25,(36),2007,pp 5715-5722
2005A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.Coates, Alan; Castiglione-Gertsch, Monica; et, al; Forbes, John F.; Gelber, Richard D. (Prof); Keshaviah, Aparna; Mauriac, Louis; Mouridsen, Henning; Paridaens, Robert; Rabaglio, Manuela; Thurlimann, Beat; School of Public Health: Public HealthA comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer., New England Journal of Medicine, vol.353,(26),2005,pp 2747-2757
2007Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98Coates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; et, al; Forbes, John F.; Gelber, Richard D. (Prof); Keshaviah, Aparna; Mauriac, Louis; Mouridsen, Henning; Paridaens, Robert; Thurlimann, Beat; School of Public Health: Public HealthFive years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98, JOURNAL OF CLINICAL ONCOLOGY 2005, vol.25,(5),2007,pp 486-492
2008Letrozole Compared With Tamoxifen for Elderly Patients With Endocrine-Responsive Early Breast Cancer: The BIG 1-98 TrialCoates, Alan; Castiglione-Gertsch, Monica; Chirgwin, Jacquie H; Colleoni, Marco; Crivellari, Diana; Del Mastro, Lucia; Forbes, John F.; Gelber, Richard D. (Prof); Gladieff, Laurence; Goldhirsch, Aron; Lang, Istvan; Mauriac, Louis; Mouridsen, Henning; Paridaens, Robert; Price, Karen; Rabaglio, Manuela; Smith, Ian (Prof); Sun, Zhuoxin; Thurlimann, Beat; School of Public Health: Public HealthLetrozole Compared With Tamoxifen for Elderly Patients With Endocrine-Responsive Early Breast Cancer: The BIG 1-98 Trial, Journal of Clinical Oncology, vol.26, 12, 2008,pp 1972-1979
2009Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.Coates, Alan; et al, various; Forbes, John F.; Giobbie-Hurder, Anita; Goldhirsch, Aron; Mauriac, Louis; Mouridsen, Henning; Paridaens, Robert; Price, Karen; Smith, Ian (Prof); Thurlimann, Beat; School of Public Health: Public HealthLetrozole therapy alone or in sequence with tamoxifen in women with breast cancer., New England Journal of Medicine, vol.361, 8,pp 766-776
2017Long-term follow-up of The Intergroup Exemestane StudyCoates, Alan; Alvarez, Isabel; Andersen, Jorn; Bertelli, Gianfilippo; Bliss, Judith; Coleman, Robert; Coombes, R. Charles; Del Mastro, Lucia; Dodwell, David; Fallowfield, L. J.; Holmberg, Stig; Jassem, Jacek; Jones, Stephen E; Kilburn, L; L√łnning, Per; Morden, James; Nicholas, Hanna; Ortmann, Olaf; Paridaens, Robert; Snowdon, Claire; van de Velde, C; NH&MRC Clinical Trials CentreLong-term follow-up of The Intergroup Exemestane Study, Journal of Clinical Oncology, vol.35, 22, 2017,pp 2507-2514
2007Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trialCoates, Alan; Debled, M.; et, al; Forbes, John F.; Keshaviah, Aparna; Lang, I.; Mauriac, L; Monnier, Arnaud; Mouridsen, Henning; Paridaens, Robert; Thurlimann, Beat; School of Public Health: Public HealthPredictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial, Annals of Oncology 2005, vol.18,(5),2007,pp 859-867
2004A Randomized Trial Of Exemestane After Two To Three Years Of Tamoxifen Therapy In Postmenopausal Women With Primary Breast Cancer.Coates, Alan; Alvarez, Isabel; Bertelli, Gianfilippo; Coombes, R Charles; Delozier, Thierry; et, al; Gibson, Lorna J; Hall, Emma; Jassem, Jacek; Jones, Stephen E; Ortmann, Olaf; Paridaens, Robert; School of Public Health: Public HealthA Randomized Trial Of Exemestane After Two To Three Years Of Tamoxifen Therapy In Postmenopausal Women With Primary Breast Cancer., New England Journal of Medicine, vol.350,(11),2004,pp 1081-1092